1. Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016; 12:412–420.
Article
2. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393:1745–1759.
Article
3. van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage. 2010; 18:605–612.
Article
4. Lafeber FP, van Spil WE. Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthritis Cartilage. 2013; 21:1452–1464.
Article
5. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001; 60:619–626.
Article
6. Hao HQ, Zhang JF, He QQ, Wang Z. Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2019; 27:726–736.
Article
7. Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017; 15:123.
Article
8. Sun Y, Brenner H, Sauerland S, Günther KP, Puhl W, Stürmer T. Serum uric acid and patterns of radiographic osteoarthritis--the Ulm Osteoarthritis Study. Scand J Rheumatol. 2000; 29:380–386.
9. Ding X, Zeng C, Wei J, Li H, Yang T, Zhang Y, et al. The associations of serum uric acid level and hyperuricemia with knee osteoarthritis. Rheumatol Int. 2016; 36:567–573.
Article
10. Krasnokutsky S, Oshinsky C, Attur M, Ma S, Zhou H, Zheng F, et al. Serum urate levels predict joint space narrowing in non-gout patients with medial knee osteoarthritis. Arthritis Rheumatol. 2017; 69:1213–1220.
Article
11. Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A. 2011; 108:2088–2093.
Article
12. Vaidya B, Bhochhibhoya M, Nakarmi S. Synovial fluid uric acid level aids diagnosis of gout. Biomed Rep. 2018; 9:60–64.
Article
13. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986; 29:1039–1049.
Article
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130:461–470.
Article
15. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16:494–502.
Article
16. Kan H, Arai Y, Kobayashi M, Nakagawa S, Inoue H, Hino M, et al. Radiographic measurement of joint space width using the fixed flexion view in 1,102 knees of Japanese patients with osteoarthritis in comparison with the standing extended view. Knee Surg Relat Res. 2017; 29:63–68.
Article
17. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005; 32:2485–2487.
18. Wu PT, Shao CJ, Wu KC, Wu TT, Chern TC, Kuo LC, et al. Pain in patients with equal radiographic grades of osteoarthritis in both knees: the value of gray scale ultrasound. Osteoarthritis Cartilage. 2012; 20:1507–1513.
Article
19. Naredo E, Cabero F, Palop MJ, Collado P, Cruz A, Crespo M. Ultrasonographic findings in knee osteoarthritis: a comparative study with clinical and radiographic assessment. Osteoarthritis Cartilage. 2005; 13:568–574.
Article
20. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016; 388:2039–2052.
Article
21. Zamudio-Cuevas Y, Martínez-Flores K, Fernández-Torres J, Loissell-Baltazar YA, Medina-Luna D, López-Macay A, et al. Monosodium urate crystals induce oxidative stress in human synoviocytes. Arthritis Res Ther. 2016; 18:117.
Article
22. He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016; 41:1012–1021.
Article
23. Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ, Qiu JH, et al. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes. J Inflamm (Lond). 2015; 12:30.
Article
24. Puig JG, Torres RJ, de Miguel E, Sánchez A, Bailén R, Banegas JR. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders. Metabolism. 2012; 61:512–518.
Article
25. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016; 213:8–14.
Article
26. Kelton J, Kelley WN, Holmes EW. A rapid method for the diagnosis of acute uric acid nephropathy. Arch Intern Med. 1978; 138:612–615.
Article
27. Choi S, Moon SJ, Kang EJ, Lee KH. Validity of random urinary uric acid-to-creatinine ratio for estimating 24-hour urine uric acid excretion in patients with gout. Ann Rheum Dis (Abstract). 2018; 77:664–665.
28. Tiitinen S, Nissilä M, Ruutsalo HM, Isomäki H. Effect of nonsteroidal anti-inflammatory drugs on the renal excretion of uric acid. Clin Rheumatol. 1983; 2:233–236.
Article
29. Chhana A, Callon KE, Pool B, Naot D, Gamble GD, Dray M, et al. The effects of monosodium urate monohydrate crystals on chondrocyte viability and function: implications for development of cartilage damage in gout. J Rheumatol. 2013; 40:2067–2074.
Article
30. Hwang HS, Yang CM, Park SJ, Kim HA. Monosodium urate crystal-induced chondrocyte death via autophagic process. Int J Mol Sci. 2015; 16:29265–29277.
Article